Does Opium Consumption Have Shared Impact on Atherosclerotic Cardiovascular Disease and Cancer?

Although atherosclerotic cardiovascular disease (ASCVD) and cancer are seemingly different types of disease, they have multiple shared underlying mechanisms and lifestyle-related risk factors like smoking, unhealthy diet, excessive alcohol consumption, and inadequate physical activity. Opium abuse is prevalent in developing countries, especially the Middle East region and many Asian countries. Besides recreational purposes, many people use opium based on a traditional belief that opium consumption may confer protection against heart attack and improve the control of the risk factors of ASCVD such as diabetes mellitus, hypertension, and dyslipidemia. However, scientific reports indicate an increased risk of ASCVD and poor control of ASCVD risk factors among opium abusers compared with nonusers. Moreover, there is accumulating evidence that opium consumption exerts potential carcinogenic effects and increases the risk of developing various types of cancer. We conducted a review of the literature to review the current evidence on the relationship between opium consumption and ASCVD as well as various kinds of cancer. In addition, we will discuss the potential shared pathophysiologic mechanisms underlying the association between opium abuse and both ASCVD and cancer.

[1]  R. Malekzadeh,et al.  Carcinogenicity of opium consumption. , 2020, The Lancet. Oncology.

[2]  R. Malekzadeh,et al.  Long-term opiate use and risk of cardiovascular mortality: results from the Golestan Cohort Study. , 2020, European journal of preventive cardiology.

[3]  R. Malekzadeh,et al.  Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study , 2020, The Lancet. Global health.

[4]  O. Mehrpour,et al.  Opium use and cardiovascular diseases: a systematic review and meta-analysis , 2020, Critical reviews in toxicology.

[5]  R. Malekzadeh,et al.  Individual and Combined Effects of Environmental Risk Factors for Esophageal Cancer Based on Results From the Golestan Cohort Study. , 2019, Gastroenterology.

[6]  R. D. de Boer,et al.  Common risk factors for heart failure and cancer , 2019, Cardiovascular research.

[7]  G. S. Sharma,et al.  Disturbed homocysteine metabolism is associated with cancer , 2019, Experimental & Molecular Medicine.

[8]  N. Shahrokhi,et al.  Effects of Opium Addiction on Some Biochemical Factors in Diabetic Rats , 2018, Addiction & health.

[9]  S. Asgary,et al.  Opium Addiction and Ischemic Stroke in Isfahan, Iran: A Case-Control Study , 2017, European Neurology.

[10]  R. Malekzadeh,et al.  Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study , 2017, Cancer Epidemiology, Biomarkers & Prevention.

[11]  C. Mantzoros,et al.  Adiponectin, lipids and atherosclerosis , 2017, Current opinion in lipidology.

[12]  N. Sarrafzadegan,et al.  Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic prevention. , 2017, Atherosclerosis.

[13]  M. Moosazadeh,et al.  Opium and bladder cancer: A systematic review and meta-analysis of the odds ratios for opium use and the risk of bladder cancer , 2017, PloS one.

[14]  R. Afshari,et al.  Opium Addiction and Risk of Laryngeal and Esophageal Carcinoma , 2017, Iranian journal of otorhinolaryngology.

[15]  L. Jahangiry,et al.  Outcomes and long-term survival of coronary artery surgery: The controversial role of opium as risk marker , 2016, World journal of cardiology.

[16]  R. Malekzadeh,et al.  Mortality from respiratory diseases associated with opium use: a population-based cohort study , 2016, Thorax.

[17]  K. Zhao,et al.  Preoperative peripheral plasma fibrinogen level is an independent prognostic marker in penile cancer , 2016, Oncotarget.

[18]  N. Khanjani,et al.  Can Opium Use Contribute to a Higher Risk of Colorectal Cancers? A Matched Case-control Study in Iran , 2016, Iranian journal of public health.

[19]  A. Sayadi,et al.  Opium addiction as an independent risk factor for coronary microvascular dysfunction: A case-control study of 250 consecutive patients with slow-flow angina. , 2016, International journal of cardiology.

[20]  H. Ghaem,et al.  Colorectal Cancer Mortality in Shiraz, Iran. , 2016, Asian Pacific journal of cancer prevention : APJCP.

[21]  F. Hu,et al.  Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study , 2016, BMC Cancer.

[22]  Mohammad R. Ostovaneh,et al.  Opium use, cigarette smoking, and alcohol consumption in relation to pancreatic cancer , 2016, Medicine.

[23]  R. Seemann,et al.  Prognostic Impact of Pretreatment Plasma Fibrinogen in Patients with Locally Advanced Oral and Oropharyngeal Cancer , 2016, PloS one.

[24]  M. R. Sadeghian,et al.  The Effect of Smoking and Opium on Bladder Cancer in Yazd Province: A Case - Control Study , 2016 .

[25]  B. Dutta,et al.  Glycated Hemoglobin (HbA1c) Correlation with Severity of Coronary Artery Disease in Non-diabetic Patients - A Hospital based Study from North-Eastern India. , 2016, Journal of clinical and diagnostic research : JCDR.

[26]  Parvinder Kumar,et al.  Methylenetetrahydrofolate reductase C677T and methionine synthase A2756G gene polymorphisms and associated risk of cardiovascular diseases: A study from Jammu region , 2016, Indian heart journal.

[27]  A. Blaes,et al.  Shared Risk Factors in Cardiovascular Disease and Cancer , 2016, Circulation.

[28]  P. Tan,et al.  Evolving role of adiponectin in cancer-controversies and update , 2016, Cancer biology & medicine.

[29]  Shan-shan Liang,et al.  Hyperfibrinogenemia predicts poor prognosis in patients with advanced biliary tract cancer , 2016, Tumor Biology.

[30]  Xiaoming Xie,et al.  The preoperative plasma fibrinogen level is an independent prognostic factor for overall survival of breast cancer patients who underwent surgical treatment. , 2015, Breast.

[31]  Chi-Chih Wang,et al.  Factor VII promotes hepatocellular carcinoma progression through ERK-TSC signaling , 2015, Cell Death Discovery.

[32]  A. Jafarian,et al.  Surgical infrainguinal revascularization for peripheral arterial disease: factors affecting patency rate , 2015, Medical journal of the Islamic Republic of Iran.

[33]  H. Harati,et al.  The Mortality Rate of Myocardial Infraction Patients With and Without Opium Dependen , 2015, International journal of high risk behaviors & addiction.

[34]  N. Khanjani,et al.  Opium as a Risk Factor for Bladder Cancer: A Population-based Case-control Study in Iran. , 2015, Archives of Iranian medicine.

[35]  N. Azdaki,et al.  Elevated Plasma Homocysteine Concentration in Opium-Addicted Individuals , 2015, Addiction & health.

[36]  Jingpu Shi,et al.  Genetic polymorphism of MTHFR C677T and premature coronary artery disease susceptibility: A meta-analysis. , 2015, Gene.

[37]  E. Ghaderi,et al.  Occupation, smoking, opium, and bladder cancer: A case–control study , 2015, South Asian Journal of Cancer.

[38]  Haijian Wu,et al.  Circulating Adiponectin and Risk of Endometrial Cancer , 2015, PloS one.

[39]  V. Bravatà Controversial roles of methylenetetrahydrofolate reductase polymorphisms and folate in breast cancer disease , 2015, International journal of food sciences and nutrition.

[40]  M. Khoshknab,et al.  Survey of the Effect of Opioid Abuse on the Extent of Coronary Artery Diseases , 2014, Global journal of health science.

[41]  M. Motamedi,et al.  Opium Usage as an Etiologic Factor of Oral Cavity Cancer , 2014, The Journal of craniofacial surgery.

[42]  Zhijian Yang,et al.  Hemoglobin A1c Risk Score for the Prediction of Coronary Artery Disease in Subjects with Angiographically Diagnosed Coronary Atherosclerosis , 2014, Cellular Physiology and Biochemistry.

[43]  M. Salarifar,et al.  Opium Consumption and Mid-Term Outcome of Percutaneous Coronary Intervention in Men , 2014, The journal of Tehran Heart Center.

[44]  W. Kim,et al.  Association between obesity-related adipokines and colorectal cancer: a case-control study and meta-analysis. , 2014, World journal of gastroenterology.

[45]  Ping Chen,et al.  Value of fibrinogen and D-dimer in predicting recurrence and metastasis after radical surgery for non-small cell lung cancer , 2014, Medical Oncology.

[46]  James H Doroshow,et al.  Molecular mechanisms underlying chronic inflammation-associated cancers. , 2014, Cancer letters.

[47]  L. Liebenberg,et al.  Does cancer risk increase with HbA1c, independent of diabetes? , 2014, British Journal of Cancer.

[48]  Navid Mohammadi,et al.  Opium dependency and in-hospital outcome of acute myocardial infarction , 2014, Medical journal of the Islamic Republic of Iran.

[49]  N. Sarrafzadegan,et al.  Effects of opium consumption on cardiometabolic diseases , 2013, Nature Reviews Cardiology.

[50]  M. Shokoohi,et al.  The effect of opium addiction on serum adiponectin and leptin levels in male subjects: a case control study from Kerman Coronary Artery Disease Risk Factors Study (KERCADRS) , 2013, EXCLI journal.

[51]  A. Shafiee,et al.  Serum Uric Acid Is Not an Independent Risk Factor for Premature Coronary Artery Disease , 2013, Cardiorenal Medicine.

[52]  R. Malekzadeh,et al.  Opium Use and Risk of Mortality from Digestive Diseases: A Prospective Cohort Study , 2013, The American Journal of Gastroenterology.

[53]  R. Malekzadeh,et al.  Opium: An emerging risk factor for gastric adenocarcinoma , 2013, International journal of cancer.

[54]  S. Aref,et al.  Impact of serum adiponectin and leptin levels in acute leukemia , 2013, Hematology.

[55]  G. Mosayebi,et al.  Cytokine Profiles in Long-Term Smokers of Opium (Taryak) , 2013, Journal of addiction medicine.

[56]  A. Haghdoost,et al.  Relation of Opium Addiction with the Severity and Extension of Myocardial Infarction and Its Related Mortality , 2013, Addiction & health.

[57]  M. Rezaeian,et al.  The plasma levels of the cytokines in opium-addicts and the effects of opium on the cytokines secretion by their lymphocytes. , 2013, Immunology letters.

[58]  N. Sarrafzadegan,et al.  Opium decreases the age at myocardial infarction and sudden cardiac death: a long- and short-term outcome evaluation. , 2013, Archives of Iranian medicine.

[59]  J. Manson,et al.  A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. , 2013, Journal of the National Cancer Institute.

[60]  M. Mohammadpour,et al.  Evaluation of the role of opium addiction in acute myocardial infarction as a risk factor. , 2013, Caspian journal of internal medicine.

[61]  Y. DeClerck,et al.  Protumorigenic activity of plasminogen activator inhibitor-1 through an antiapoptotic function. , 2012, Journal of the National Cancer Institute.

[62]  M. Rezvani,et al.  Is opium addiction a risk factor for ischemic heart disease and ischemic stroke? , 2012, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[63]  A. Salehi,et al.  The relationship between coronary risk factors and coronary artery involvement based on angiogrpahy findings. , 2012 .

[64]  S. Joukar,et al.  Combination of opium smoking and hypercholesterolemia augments susceptibility for lethal cardiac arrhythmia and atherogenesis in rabbit. , 2012, Environmental toxicology and pharmacology.

[65]  S. Hursting,et al.  Growth Signals, Inflammation, and Vascular Perturbations: Mechanistic Links Between Obesity, Metabolic Syndrome, and Cancer , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[66]  M. Najafi,et al.  Does Analgesic Effect of Opium Hamper the Adverse Effects of Severe Coronary Artery Disease on Quality of Life in Addicted Patients? , 2012, Anesthesiology and pain medicine.

[67]  T. Urano,et al.  PAI‐1, progress in understanding the clinical problem and its aetiology , 2012, British journal of haematology.

[68]  J. K. Kundu,et al.  Emerging avenues linking inflammation and cancer. , 2012, Free radical biology & medicine.

[69]  R. Malekzadeh,et al.  Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50 000 adults in Iran , 2012, BMJ : British Medical Journal.

[70]  Qin Yang,et al.  Association between polymorphism of methylenetetrahydrofolate reductase (MTHFR) C677T and risk of myocardial infarction: a meta-analysis for 8,140 cases and 10,522 controls. , 2011, Archives of medical research.

[71]  V. Ploplis Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease. , 2011, Current drug targets.

[72]  A. Rahimi-Foroushani,et al.  Opium consumption and coronary atherosclerosis in diabetic patients: a propensity score-matched study. , 2011, Planta medica.

[73]  P. Marino,et al.  High fibrinogen level is an independent predictor of presence and extent of coronary artery disease among Italian population , 2011, Journal of Thrombosis and Thrombolysis.

[74]  A. Mirzazadeh,et al.  Abrupt opium discontinuation has no significant triggering effect on acute myocardial infarction , 2011, Journal of cardiovascular medicine.

[75]  E. Amini,et al.  Opium consumption and risk of bladder cancer: A case-control analysis. , 2010, Urologic oncology.

[76]  M. Masoomi,et al.  The Relationship of Opium Addiction with Coronary Artery Disease , 2010, International journal of preventive medicine.

[77]  M. Salarifar,et al.  Opium consumption in men and diabetes mellitus in women are the most important risk factors of premature coronary artery disease in Iran. , 2010, International journal of cardiology.

[78]  R. Krasuski,et al.  Impact of Fibrinogen Levels on Angiographic Progression and 12-Year Survival in the Armed Forces Regression Study , 2010, Angiology.

[79]  G. Bu,et al.  LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy , 2010, Proceedings of the National Academy of Sciences.

[80]  S. Joukar,et al.  Passive opium smoking does not have beneficial effect on plasma lipids and cardiovascular indices in hypercholesterolemic rabbits with ischemic and non-ischemic hearts. , 2010, Journal of ethnopharmacology.

[81]  R. Malekzadeh,et al.  Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern Iran. , 2010, International journal of epidemiology.

[82]  S. Joukar,et al.  The Effect of Passive Opium Smoking on Cardiovascular Indices of Rabbits with Normal and Ischemic Hearts , 2010, The open cardiovascular medicine journal.

[83]  Clemens Tempfer,et al.  Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study. , 2009, The oncologist.

[84]  J. Fichna,et al.  The Influence of Opioids on Urokinase Plasminogen Activator on Protein and mRNA Level in MCF‐7 Breast Cancer Cell Line , 2009, Chemical biology & drug design.

[85]  Alberto Mantovani,et al.  Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.

[86]  A. Mohammadi,et al.  Effect of opium addiction on lipid profile and atherosclerosis formation in hypercholesterolemic rabbits. , 2009, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[87]  E. Arısan,et al.  Serum Adipocytokine Levels in Prostate Cancer Patients , 2009, Urologia Internationalis.

[88]  Serap Yıldırım,et al.  Serum adiponectin levels in patients with esophageal cancer. , 2008, Japanese journal of clinical oncology.

[89]  S. Asgary,et al.  Lipids in Health and Disease , 2008 .

[90]  E. Hajizadeh,et al.  Cultural barriers in the education of cardiovascular disease patients in Iran. , 2008, International nursing review.

[91]  P Boffetta,et al.  Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran , 2008, British Journal of Cancer.

[92]  M. Salarifar,et al.  The association of opium with coronary artery disease , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[93]  M. Karbakhsh,et al.  Acute opiate overdose in Tehran: the forgotten role of opium. , 2007, Addictive behaviors.

[94]  A. Laraqui,et al.  Thermolabile Methylenetetrahydrofolate Reductase C677T Polymorphism and Homocysteine Are Risk Factors for Coronary Artery Disease in Moroccan Population , 2007, Journal of biomedicine & biotechnology.

[95]  M. Abtahi EVALUATION OF BLADDER CANCER IN OPIUM ADDICTED PATIENTS IN THE KERMAN PROVINCE, IRAN FROM 1999 TO 2003 , 2006 .

[96]  Dong Kun Lee,et al.  Activation of the canonical Wnt/beta-catenin pathway enhances monocyte adhesion to endothelial cells. , 2006, Biochemical and biophysical research communications.

[97]  Chuanshu Huang,et al.  Inflammation, a Key Event in Cancer Development , 2006, Molecular Cancer Research.

[98]  M. Ahmadinejad,et al.  EVALUATION OF BLADDER CANCER IN OPIUM ADDICTED PATIENTS IN THE KERMAN PROVINCE, IRAN, FROM 1999 TO 2003 , 2005 .

[99]  B. Sarwar,et al.  A Case-Control Study of Effect of Opium Addiction on Myocardial Infarction , 2005 .

[100]  K. G. Z. Izadimoud IS OPIUM ADDICTION A RISK FACTOR FOR ACUTE MYOCARDIAL INFARCTION , 2005 .

[101]  H. Nagawa,et al.  Plasma adiponectin and gastric cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[102]  J. Schlesselman,et al.  Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk. , 2004, International journal of oncology.

[103]  Kongpetch Kulsudjarit Drug Problem in Southeast and Southwest Asia , 2004, Annals of the New York Academy of Sciences.

[104]  M. Khaksari,et al.  Effects of opium addiction on some serum factors in addicts with non‐insulin‐dependent diabetes mellitus , 2004, Addiction biology.

[105]  C. Mantzoros,et al.  Adiponectin and breast cancer risk. , 2004, The Journal of clinical endocrinology and metabolism.

[106]  D. Richel,et al.  Coagulation factors VIIa and Xa inhibit apoptosis and anoikis , 2004, Oncogene.

[107]  A. Khamesipour,et al.  Opium and risk of laryngeal cancer , 2003, The Laryngoscope.

[108]  T. Hembrough,et al.  Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. , 2003, Cancer research.

[109]  V. Salomaa,et al.  Hemostatic Factors as Predictors of Coronary Events and Total Mortality: The FINRISK ’92 Hemostasis Study , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[110]  J. Plutzky Inflammatory pathways in atherosclerosis and acute coronary syndromes. , 2001, The American journal of cardiology.

[111]  C. Bode,et al.  Regulation of PAI-1 expression by genetic polymorphisms. Impact on atherogenesis. , 2001, Thrombosis research.

[112]  M. Duffy Urokinase-type plasminogen activator: a potent marker of metastatic potential in human cancers. , 2001, Biochemical Society transactions.

[113]  V. Salomaa,et al.  Prospective Study of Fibrinolytic Factors and Incident Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[114]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[115]  J. Townend,et al.  Homocysteine and atherothrombosis--mechanisms for injury. , 2000, European heart journal.

[116]  M. Skobe,et al.  Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization , 1998, Nature Medicine.

[117]  K. Becker,et al.  Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. , 1994, Cancer research.

[118]  T. Meade,et al.  Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study , 1993, The Lancet.

[119]  N. Day,et al.  Oesophageal cancer studies in the caspian littoral of Iran: Some residual results, including opium use as a risk factor , 1985, International journal of cancer.

[120]  S. Vesselinovitch,et al.  Opium: A potential urinary bladder carcinogen in man , 1979, Cancer.

[121]  P. Novak,et al.  [The effect of smoking on the quality of life enhancement following prosthetic rehabilitation in head and neck cancer patients who underwent surgical treatment]. , 2017, Orvosi hetilap.

[122]  M. Shabani,et al.  Impact of Opium Addiction on Levels of Pro- and Anti-inflammatory Cytokines after Surgery , 2016, Addiction & health.

[123]  H. Shafi,et al.  Age distribution types of bladder cancers and their relationship with opium consumption and smoking , 2015, Caspian journal of internal medicine.

[124]  R. Malekzadeh,et al.  Neglected role of hookah and opium in gastric carcinogenesis: A cohort study on risk factors and attributable fractions , 2014, International journal of cancer.

[125]  Reza Malekpour-afshar,et al.  Serum Level of Plasminogen Activator Inhibitor Type-1 in Addicted Patients with Coronary Artery Disease , 2014, Addiction & health.

[126]  N. Khanjani,et al.  Frequency of Opium Addiction in Patients with Ischemic Stroke and Comparing their Cerebrovascular Doppler Ultrasound Changes to Non-Addicts , 2013, Addiction & health.

[127]  M. Shokoohi,et al.  The effect of opium addiction on arrhythmia following acute myocardial infarction. , 2012, Acta medica Iranica.

[128]  B. Eshrati,et al.  Prominent bladder cancer risk factors in Iran. , 2010, Asian Pacific journal of cancer prevention : APJCP.

[129]  M. Esfandbod,et al.  Can opium abuse be a risk factor for carotid stenosis in patients who are candidates for coronary artery bypass grafting? , 2010, Cardiology journal.

[130]  A. Mirzazadeh,et al.  Opium addiction and severity of coronary artery disease: a case-control study , 2010, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[131]  D. Lu,et al.  Treatment of solid tumors and metastases by fibrinogen-targeted anticancer drug therapy. , 2007, Medical hypotheses.

[132]  S. Darvish,et al.  COMPARISON OF SPECIFICATIONS, SHORT TERM OUTCOME AND PROGNOSIS OF ACUTE MYOCARDIAL INFARCTION IN OPIUM DEPENDENT PATIENTS AND NONDEPENDENTS , 2006 .

[133]  A. Nourbakhsh,et al.  OPIUM USE IN TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER , 2006 .

[134]  D. Labuda,et al.  Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. , 2004, Blood.

[135]  H. Dvorak,et al.  Fibrin as a component of the tumor stroma: origins and biological significance , 2004, Cancer and Metastasis Reviews.

[136]  L. Gachkar,et al.  Is bladder cancer more common among opium addicts? , 2004, Urology journal.

[137]  J. Guilbert The world health report 2002 - reducing risks, promoting healthy life. , 2003, Education for health.

[138]  K. Matsuo,et al.  Methionine Synthase Reductase Gene A66G Polymorphism is Associated with Risk of Colorectal Cancer. , 2002, Asian Pacific journal of cancer prevention : APJCP.

[139]  H. Nasri,et al.  COMPARISON OF PLASMA FIBRINOGEN LEVEL IN OPIUM ADDICT MEN WITH NON-ADDICT MEN , 2002 .